Abstract
antipsychotic drugs are regularly prescribed as first-line treatment for neuropsychiatric symptoms in persons with dementia although guidelines clearly prioritise non-pharmacological interventions. we investigated a person-centred care approach, which has been successfully evaluated in nursing homes in the UK, and adapted it to German conditions. a 2-armed 12-month cluster-randomised controlled trial. nursing homes in East, North and West Germany. all prescribing physicians from both study arms received medication reviews for individual patients and were offered access to 2 h of continuing medical education. Nursing homes in the intervention group received educational interventions on person-centred care and a continuous supervision programme. Primary outcome: proportion of residents receiving at least one antipsychotic prescription after 12 months of follow-up. Secondary outcomes: quality of life, agitated behaviour, falls and fall-related medical attention, a health economics evaluation and a process evaluation. the study was conducted in 37 nursing homes with n = 1,153 residents (intervention group: n = 493; control group: n = 660). The proportion of residents with at least one antipsychotic medication changed after 12 month...Continue Reading
References
May 1, 1989·Journal of Gerontology·J Cohen-MansfieldA S Rosenthal
Mar 2, 1999·American Journal of Respiratory and Critical Care Medicine·F GallefossP K Rsgaard
Oct 20, 2001·Ageing and Society·Murna Downs
Mar 4, 2005·BMC Medical Research Methodology·Seokyung HahnJudith Watson
Mar 18, 2006·BMJ : British Medical Journal·Jane FosseyRobert Howard
Sep 21, 2007·Age and Ageing·Leonore KöhlerMartina Schäufele
Apr 21, 2010·European Journal of Clinical Pharmacology·Kathrine F VandraasLars Slørdal
Sep 10, 2010·Deutsches Ärzteblatt International·Stefanie HoltPetra A Thürmann
May 24, 2012·JAMA : the Journal of the American Medical Association·Sascha KöpkeGabriele Meyer
Dec 14, 2012·The Cochrane Database of Systematic Reviews·Tanja RichterSascha Köpke
Feb 19, 2014·International Journal of Geriatric Psychiatry·Jane FosseyClive Ballard
Feb 24, 2015·Journal of the American Medical Directors Association·Angela M SanfordBruno Vellas
Mar 21, 2015·BMJ : British Medical Journal·Graham F MooreJanis Baird
Apr 8, 2015·International Journal of Geriatric Psychiatry·Ingelin TestadØyvind Kirkevold
Jun 4, 2015·Implementation Science : IS·Christin RichterGabriele Meyer
Jul 15, 2015·Aging & Mental Health·Dawn J BrookerJames Pickett
Jul 30, 2016·International Psychogeriatrics·Sarah I M JanusSytse U Zuidema
Feb 18, 2017·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Julia KirkhamDallas Seitz
Mar 4, 2017·Clinical Interventions in Aging·Sun Kyung Kim, Myonghwa Park
Feb 7, 2018·PLoS Medicine·Clive BallardJane Fossey
Feb 27, 2018·Journal of the American Medical Directors Association·Elizabeth G Birkenhäger-GillesseSytse U Zuidema
Aug 14, 2018·Journal of the American Medical Directors Association·Ellen Van LeeuwenThierry Christiaens
Citations
Apr 19, 2020·BMC Geriatrics·Rieke SchnakenbergFalk Hoffmann
Jul 18, 2020·Trials·Katharina SiliesSascha Köpke
Oct 14, 2019·BMC Psychiatry·Claudia M Groot KormelinckSytse U Zuidema
May 31, 2019·Trials·Natalie NguyenGabriele Meyer
Jan 13, 2021·BMC Geriatrics·Martin N DichterSascha Köpke
Aug 31, 2020·Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen·Claudia KirschHannah Haumann
Mar 23, 2021·European Geriatric Medicine·Anne SpinewineCarmel Hughes
Apr 30, 2021·BMC Nursing·Mari PakkonenRiitta Suhonen
May 24, 2021·BMC Geriatrics·Mireia Massot MesquidaPere Torán Monserrat
Jun 2, 2021·Expert Opinion on Drug Safety·Elizabeth ManiasNarelle Borrott
Nov 7, 2020·Trials·Christiane MüllerEva Hummers
Jul 5, 2021·BMC Geriatrics·Claudia M Groot KormelinckDebby L Gerritsen